Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021

 

Upgrades

  • According to B of A Securities, the prior rating for Bloom Energy Corp BE was changed from Underperform to Neutral. For the first quarter, Bloom Energy had an EPS of $0.07, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $44.95 and a 52-week-low of $7.71. At the end of the last trading period, Bloom Energy closed at $24.66.
  • Stephens & Co. upgraded the previous rating for Redfin Corp RDFN from Equal-Weight to Overweight. Redfin earned $0.37 in the first quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $98.44 and a 52-week-low of $29.70. At the end of the last trading period, Redfin closed at $58.71.
  • Barclays upgraded the previous rating for Ovintiv Inc OVV from Underweight to Overweight. Ovintiv earned $1.10 in the first quarter. At the moment, the stock has a 52-week-high of $30.02 and a 52-week-low of $6.81. Ovintiv closed at $29.61 at the end of the last trading period.
  • For Occidental Petroleum Corp OXY, Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, Occidental Petroleum had an EPS of $0.15, compared to year-ago quarter EPS of $0.52. The current stock performance of Occidental Petroleum shows a 52-week-high of $32.52 and a 52-week-low of $8.52. Moreover, at the end of the last trading period, the closing price was at $29.23.
  • For EOG Resources Inc EOG, Barclays upgraded the previous rating of Equal-Weight to Overweight. EOG Resources earned $1.62 in the first quarter, compared to $0.55 in the year-ago quarter. The stock has a 52-week-high of $86.60 and a 52-week-low of $31.22. At the end of the last trading period, EOG Resources closed at $85.27.
  • For MorphoSys AG MOR, SVB Leerink upgraded the previous rating of Market Perform to Outperform. MorphoSys earned $1.53 in the first quarter, compared to $6.74 in the year-ago quarter. The current stock performance of MorphoSys shows a 52-week-high of $35.73 and a 52-week-low of $18.55. Moreover, at the end of the last trading period, the closing price was at $19.20.
  • For AvalonBay Communities Inc AVB, Mizuho upgraded the previous rating of Neutral to Buy. AvalonBay Communities earned $1.95 in the first quarter, compared to $2.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $213.67 and a 52-week-low of $131.38. AvalonBay Communities closed at $212.75 at the end of the last trading period.
  • According to Mizuho, the prior rating for Douglas Emmett Inc DEI was changed from Neutral to Buy. In the first quarter, Douglas Emmett showed an EPS of $0.44, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $36.78 and a 52-week-low of $22.88. At the end of the last trading period, Douglas Emmett closed at $36.77.
  • Roth Capital upgraded the previous rating for Semtech Corp SMTC from Neutral to Buy. In the first quarter, Semtech showed an EPS of $0.53, compared to $0.35 from the year-ago quarter. The current stock performance of Semtech shows a 52-week-high of $83.94 and a 52-week-low of $48.50. Moreover, at the end of the last trading period, the closing price was at $61.93.
  • Stifel upgraded the previous rating for Criteo SA CRTO from Hold to Buy. For the first quarter, Criteo had an EPS of $0.67, compared to year-ago quarter EPS of $0.52. The stock has a 52-week-high of $42.50 and a 52-week-low of $10.28. At the end of the last trading period, Criteo closed at $37.37.
  • Jefferies upgraded the previous rating for Take-Two Interactive Software Inc TTWO from Hold to Buy. In the fourth quarter, Take-Two Interactive showed an EPS of $1.40, compared to $1.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $214.91 and a 52-week-low of $124.86. Take-Two Interactive closed at $176.91 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • MKM Partners downgraded the previous rating for Continental Resources Inc CLR from Buy to Neutral. For the first quarter, Continental Resources had an EPS of $0.77, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $36.45 and a 52-week-low of $11.09. Continental Resources closed at $35.84 at the end of the last trading period.
  • For MorphoSys AG MOR, Bryan Garnier downgraded the previous rating of Buy to Neutral. MorphoSys earned $1.53 in the first quarter, compared to $6.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $35.73 and a 52-week-low of $18.55. MorphoSys closed at $19.20 at the end of the last trading period.
  • Cowen & Co. downgraded the previous rating for Constellation Pharmaceuticals Inc CNST from Outperform to Market Perform. Constellation earned $0.84 in the first quarter, compared to $0.61 in the year-ago quarter. The current stock performance of Constellation shows a 52-week-high of $40.84 and a 52-week-low of $17.00. Moreover, at the end of the last trading period, the closing price was at $33.57.
  • According to Barclays, the prior rating for APA Corp APA was changed from Overweight to Equal-Weight. APA earned $0.91 in the first quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $23.86 and a 52-week-low of $7.45. At the end of the last trading period, APA closed at $23.52.
  • Barclays downgraded the previous rating for Continental Resources Inc CLR from Equal-Weight to Underweight. For the first quarter, Continental Resources had an EPS of $0.77, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $36.45 and a 52-week-low of $11.09. At the end of the last trading period, Continental Resources closed at $35.84.
  • For Cimarex Energy Co XEC, Barclays downgraded the previous rating of Overweight to Equal-Weight. Cimarex Energy earned $1.98 in the first quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Cimarex Energy shows a 52-week-high of $74.92 and a 52-week-low of $22.39. Moreover, at the end of the last trading period, the closing price was at $70.96.
  • For Consolidated Communications Holdings Inc CNSL, Citigroup downgraded the previous rating of Neutral to Sell. In the first quarter, Consolidated Comms Hldgs showed an EPS of $0.21, compared to $0.23 from the year-ago quarter. The stock has a 52-week-high of $9.89 and a 52-week-low of $4.45. At the end of the last trading period, Consolidated Comms Hldgs closed at $9.62.
  • For Progenity Inc PROG, Raymond James downgraded the previous rating of Outperform to Market Perform. In the first quarter, Progenity earned $0.52. The current stock performance of Progenity shows a 52-week-high of $10.27 and a 52-week-low of $2.11. Moreover, at the end of the last trading period, the closing price was at $2.19.
  • Citigroup downgraded the previous rating for Allstate Corp ALL from Buy to Neutral. In the first quarter, Allstate showed an EPS of $6.11, compared to $3.54 from the year-ago quarter. The current stock performance of Allstate shows a 52-week-high of $140.00 and a 52-week-low of $84.97. Moreover, at the end of the last trading period, the closing price was at $138.14.
  • Goldman Sachs downgraded the previous rating for Benefitfocus Inc BNFT from Neutral to Sell. For the first quarter, Benefitfocus had an EPS of $0.01, compared to year-ago quarter EPS of $0.21. The current stock performance of Benefitfocus shows a 52-week-high of $17.58 and a 52-week-low of $9.36. Moreover, at the end of the last trading period, the closing price was at $14.76.
  • According to Goldman Sachs, the prior rating for Vertex Inc VERX was changed from Neutral to Sell. Vertex earned $0.07 in the first quarter. The current stock performance of Vertex shows a 52-week-high of $39.71 and a 52-week-low of $16.06. Moreover, at the end of the last trading period, the closing price was at $19.68.
  • For Sapiens International Corp NV SPNS, Goldman Sachs downgraded the previous rating of Neutral to Sell. Sapiens Intl Corp earned $0.27 in the first quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $35.85 and a 52-week-low of $22.96. At the end of the last trading period, Sapiens Intl Corp closed at $28.94.

See all analyst ratings downgrades.

 

Initiations

  • Maxim Group initiated coverage on BM Technologies Inc BMTX with a Buy rating. The price target for BM Technologies is set to $25.00. Interestingly, in the first quarter, BM Technologies's EPS was $0.25. The current stock performance of BM Technologies shows a 52-week-high of $18.35 and a 52-week-low of $8.46. Moreover, at the end of the last trading period, the closing price was at $12.73.
  • With an Outperform rating, Northland Capital Markets initiated coverage on FTAC Olympus Acquisition Corp FTOC. The price target seems to have been set at $14.00 for FTAC Olympus Acquisition. The stock has a 52-week-high of $14.50 and a 52-week-low of $9.60. At the end of the last trading period, FTAC Olympus Acquisition closed at $10.04.
  • With a Buy rating, BWS Financial initiated coverage on Garrett Motion Inc GTX. The price target seems to have been set at $15.00 for Garrett Motion. In the first quarter, Garrett Motion earned $1.27. The current stock performance of Garrett Motion shows a 52-week-high of $8.90 and a 52-week-low of $1.70. Moreover, at the end of the last trading period, the closing price was at $8.15.
  • With an Outperform rating, CJS Securities initiated coverage on Thryv Holdings Inc THRY. The price target seems to have been set at $42.00 for Thryv Holdings. Interestingly, in the first quarter, Thryv Holdings's EPS was $1.07. At the moment, the stock has a 52-week-high of $33.40 and a 52-week-low of $8.10. Thryv Holdings closed at $28.27 at the end of the last trading period.
  • With a Buy rating, Benchmark initiated coverage on WideOpenWest Inc WOW. The price target seems to have been set at $25.00 for WideOpenWest. In the first quarter, WideOpenWest showed an EPS of $0.11, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.20 and a 52-week-low of $4.72. WideOpenWest closed at $16.62 at the end of the last trading period.
  • Guggenheim initiated coverage on Generac Holdings Inc GNRC with a Buy rating. The price target for Generac Hldgs is set to $420.00. In the first quarter, Generac Hldgs showed an EPS of $2.38, compared to $0.87 from the year-ago quarter. The stock has a 52-week-high of $364.00 and a 52-week-low of $101.72. At the end of the last trading period, Generac Hldgs closed at $320.69.
  • For Enphase Energy Inc ENPH, Guggenheim initiated coverage, by setting the current rating at Neutral. In the first quarter, Enphase Energy showed an EPS of $0.56, compared to $0.38 from the year-ago quarter. At the moment, the stock has a 52-week-high of $229.04 and a 52-week-low of $37.81. Enphase Energy closed at $139.17 at the end of the last trading period.
  • With a Buy rating, Guggenheim initiated coverage on Sunnova Energy International Inc NOVA. The price target seems to have been set at $51.00 for Sunnova Energy Intl. Sunnova Energy Intl earned $0.31 in the first quarter, compared to $0.85 in the year-ago quarter. The current stock performance of Sunnova Energy Intl shows a 52-week-high of $57.70 and a 52-week-low of $13.85. Moreover, at the end of the last trading period, the closing price was at $28.27.
  • Goldman Sachs initiated coverage on Qiagen NV QGEN with a Neutral rating. The price target for Qiagen is set to $52.00. In the first quarter, Qiagen showed an EPS of $0.66, compared to $0.34 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.00 and a 52-week-low of $42.22. Qiagen closed at $47.06 at the end of the last trading period.
  • With a Buy rating, Guggenheim initiated coverage on SolarEdge Technologies Inc SEDG. The price target seems to have been set at $314.00 for SolarEdge Technologies. In the first quarter, SolarEdge Technologies showed an EPS of $0.98, compared to $0.95 from the year-ago quarter. The current stock performance of SolarEdge Technologies shows a 52-week-high of $377.00 and a 52-week-low of $127.19. Moreover, at the end of the last trading period, the closing price was at $247.48.
  • With an Overweight rating, Piper Sandler initiated coverage on Vimeo Inc VMEO. The price target seems to have been set at $52.00 for Vimeo. The current stock performance of Vimeo shows a 52-week-high of $47.85 and a 52-week-low of $38.00. Moreover, at the end of the last trading period, the closing price was at $40.81.
  • With a Buy rating, Goldman Sachs initiated coverage on Guardant Health Inc GH. The price target seems to have been set at $160.00 for Guardant Health. Guardant Health earned $0.04 in the first quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Guardant Health shows a 52-week-high of $181.07 and a 52-week-low of $74.31. Moreover, at the end of the last trading period, the closing price was at $117.35.
  • With a Buy rating, Goldman Sachs initiated coverage on Exact Sciences Corp EXAS. The price target seems to have been set at $160.00 for Exact Sciences. Exact Sciences earned $0.18 in the first quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Exact Sciences shows a 52-week-high of $159.54 and a 52-week-low of $70.75. Moreover, at the end of the last trading period, the closing price was at $109.12.
  • Goldman Sachs initiated coverage on NeoGenomics Inc NEO with a Buy rating. The price target for NeoGenomics is set to $55.00. NeoGenomics earned $0.39 in the first quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $61.57 and a 52-week-low of $25.30. At the end of the last trading period, NeoGenomics closed at $40.25.
  • With a Sell rating, Goldman Sachs initiated coverage on Myriad Genetics Inc MYGN. The price target seems to have been set at $25.00 for Myriad Genetics. Myriad Genetics earned $0.06 in the third quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $33.97 and a 52-week-low of $10.54. Myriad Genetics closed at $28.18 at the end of the last trading period.
  • With a Neutral rating, Goldman Sachs initiated coverage on Invitae Corp NVTA. The price target seems to have been set at $33.00 for Invitae. Invitae earned $0.63 in the first quarter, compared to $0.80 in the year-ago quarter. The current stock performance of Invitae shows a 52-week-high of $61.59 and a 52-week-low of $15.22. Moreover, at the end of the last trading period, the closing price was at $28.49.
  • Goldman Sachs initiated coverage on CareDx Inc CDNA with a Buy rating. The price target for CareDx is set to $95.00. CareDx earned $0.14 in the first quarter, compared to $0.00 in the year-ago quarter. The stock has a 52-week-high of $99.83 and a 52-week-low of $29.85. At the end of the last trading period, CareDx closed at $80.02.
  • With a Neutral rating, Goldman Sachs initiated coverage on Quotient Ltd QTNT. The price target seems to have been set at $5.00 for Quotient. Quotient earned $0.39 in the fourth quarter, compared to $0.31 in the year-ago quarter. The current stock performance of Quotient shows a 52-week-high of $8.77 and a 52-week-low of $3.41. Moreover, at the end of the last trading period, the closing price was at $4.42.
  • With a Neutral rating, Goldman Sachs initiated coverage on Organon & Co OGNW. The price target seems to have been set at $35.00 for Organon. At the moment, the stock has a 52-week-high of $38.75 and a 52-week-low of $31.00. Organon closed at $35.26 at the end of the last trading period.
  • Goldman Sachs initiated coverage on Vontier Corp VNT with a Neutral rating. The price target for Vontier is set to $40.00. Interestingly, in the first quarter, Vontier's EPS was $0.63. The stock has a 52-week-high of $36.77 and a 52-week-low of $27.63. At the end of the last trading period, Vontier closed at $34.60.
  • Barclays initiated coverage on Arrival ARVL with an Overweight rating. The price target for Arrival is set to $25.00. At the moment, the stock has a 52-week-high of $24.98 and a 52-week-low of $12.59. Arrival closed at $20.25 at the end of the last trading period.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!